Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMS203 Tablets in Erectile Dysfunction Phase II Crossover Trial
CTR20234083Phase 2Completed
- Sponsor
- Shandong Lukang Pharmaceutical Co., Ltd., Jinan Meiluwei Biotechnology Co., Ltd., Shanghai Zhongtuo Pharmaceutical Technology Co., Ltd.
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CMS203 in erectile dysfunction (ED), sponsored by Shandong Lukang Pharmaceutical Co., Ltd., Jinan Meiluwei Biotechnology Co., Ltd., Shanghai Zhongtuo Pharmaceutical Technology Co., Ltd.. Started Dec 2023; status: completed.
02
Drugs
CMS203
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20234083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234083.